Treatment of Dyspareunia with Botulinum Neurotoxin Type A: Clinical Improvement and Influence of Patients’ Characteristics

Treatment of Dyspareunia with Botulinum Neurotoxin Type A: Clinical Improvement and Influence of Patients’ Characteristics

The treatment of chronic pelvic pain (CPP) with botulinum neurotoxin type A (BoNT/A) has increased lately, but more studies assessing its effect are needed. This study aimed to evaluate the evolution of patients after BoNT/A infiltration and identify potential responders to treatment. Twenty-four wo...

Full description

Bibliographic Details
Main Authors: Marta Tarazona-Motes, Monica Albaladejo-Belmonte, Francisco J. Nohales-Alfonso, Maria De-Arriba, Javier Garcia-Casado, Jose Alberola-Rubio
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Environmental Research and Public Health
Subjects:
botulinum toxin
dyspareunia
chronic pelvic pain
surface electromyography
Online Access:https://www.mdpi.com/1660-4601/18/16/8783

Internet

https://www.mdpi.com/1660-4601/18/16/8783

Similar Items